Compound 23

CAS No. 2417296-84-3

Compound 23( —— )

Catalog No. M24115 CAS No. 2417296-84-3

Compound 23 selectively induces degradation of BRAF-V600E but not wildtype BRAF.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 479 In Stock
10MG 627 In Stock
25MG 1026 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Compound 23
  • Note
    Research use only, not for human use.
  • Brief Description
    Compound 23 selectively induces degradation of BRAF-V600E but not wildtype BRAF.
  • Description
    Compound 23 selectively induces degradation of BRAF-V600E but not wildtype BRAF.
  • In Vitro
    PROTAC BRAF-V600E degrader-1 (compound 23) (1 nM-10 μM; 72 h) inhibits the cell viability of A375 and HT-29.PROTAC BRAF-V600E degrader-1 (1-1000 nM; 16 h or 0-24 h) inhibits p-ERK and BRAF-V600E protein in A375 cells. Cell Viability Assay Cell Line:A375 and HT-29 Concentration:1 nM-10 μM Incubation Time:72 h Result:Inhibited the cell viability of A375 and HT-29 with IC50s of 46.5 nM and 51 nM.Western Blot Analysis Cell Line:A375 Concentration:1, 4, 12, 37, 111, 333 and 1000 nM Incubation Time:16 h or 0-24 h Result:Induced the reduction in the phosphorylation of ERK.Inhibited p-ERK and BRAF-V600E in a dose- and time-dependent manner.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    B-Raf (V600E)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2417296-84-3
  • Formula Weight
    1001.07
  • Molecular Formula
    C48H54F2N10O10S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CCCS(=O)(NC1=CC=C(F)C(N2C=C(C3=CN=CN=C3)C4=NC(N(C5CCN(C(CCOCCOCCOCCNC6=CC=CC(C(N7C(CC8)C(NC8=O)=O)=O)=C6C7=O)=O)CC5)C)=CC=C42)=C1F)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Han X R , Chen L , Wei Y , et al. Discovery of Selective Small Molecule Degraders of BRAF-V600E[J]. Journal of Medicinal Chemistry, 2020, XXXX(XXX).
molnova catalog
related products
  • Sorafenib-d3

    Sorafenib-d3 is a deuterium-labeled Sorafenib which is a multikinase inhibitor(IC50s: 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively).

  • Sorafenib

    A potent, orally available Raf inhibitor with IC50 of 6, 22, and 38 nM for Raf-1, wt Braf, and BRaf V599E, respectively.

  • Lonafarnib

    Lonafarnib is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Phase 3.